1. ElSohly, M.A., Radwan, M.M., Gul W., Chandra S. and Galal, A. (2017). Phytochemistry of Cannabis sativa L. in Phytocannabinoids: Unravelling the complex chemistry and pharmacology of Cannabis sativa. Springer International Publishing Switzerland, 1-36. 2. Burstein, S. (2015). Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorgan. Med. Chem. 23, 1377–1385. 3. Andre, C.M., Hausman, J. and Guerriero, G. (2016). Cannabis sativa: The plant of the thousand and one molecules. Frontier in Plant Science. 7(19). 4. Giacoppo, S., Mandolino, G., Galuppo, M., Bramanti, P. and Mazzon, E. (2014). Cannabinoids: new promising agents in the treatment of neurological diseases. Molecules. 19, 18781–18816. 5. Javid F.A., Phillips, R.M., Afshinjavid, S., Verde, R and Ligresti, A. (2016). Cannabinoid pharmacology in cancer research: A new hope for cancer patients? European Journal of Pharmacology, 775, 1-14 6. DeLong, G. T., Wolf, C. E., Poklis, A., and Lichtman, A. H. (2010). Pharmacological evaluation of the natural constituent of Cannabis sativa, Cannabichromene and its modulation by tetrahydrocannabinol. Drug Alcohol Depend. 112,126–133. 7. Isahq M.S., Afridi, M.S., Ali, J., Hussain, M.M., Ahmad, S. and Kanwal, S. (2015). Proximate composition, phytochemical screening, GC-MS studies of biologically active cannabinoids and antimicrobial activities of Cannabis indica. Asian Pacific Journal of Tropical Disease. 5 (11), 897-902. 8. Rajan,T.S., Giacoppo,S.,Iori, R., De Nicola, G.S., Grassi, G., Pollastro, F., Bramanti, P. and Mazzon, E. (2016). Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages. Fitoterapia. 112,104-115. 9. Gould, J. (2015). The Cannabis crop. Nature. 525, S2–S3. 10. Lipinski, C.A. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25. 11. Abraham, M.H., Chada, H.S., Mitchell, R.C.(1994). Hydrogen bonding. 33 factors that influence the distribution of solutes between blood and brain. J. Pharm. Sci. 83,1257–1268. 12. Krämer, S.D., Aschmann, H.E., Hatibovic,M., Hermann, K.F., Neuhaus, C.S., Brunner, C., Belli, S. (2016). When barriers ignore the “rule-of-five”. Adv. Drug Deliv. Rev. 62-74. 13. Prasanna, S., Doerrksen, R.J. (2009). Topological polar surface area: A useful descriptor in 2D-QSAR. Curr Med Chem. 16:21-41. 14. Yu, C., Zhang X.D., Guan, H.Y., Gr, C.H., Wu, Y., Han, G.X. (2007). Prediction of solvation for energy of small organic moleculars based on support vector regression algorithm. Chemistrymag 9:54. 15. Macarron, R., Leungo, J.I., (2011). Yin and Yang in medicinal chemistry: what does drug-likeness mean? Future Med.Chem. 3:505-507. 16. Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Rev. 46:3-26 17. Benet, L.Z., Hosey, C.M., Ursu, O., Oprea, T.I. (2016). BDDCS, the Rule of 5 and drugability. Adv Drug Rev.101:89-98. 18. Wu, C.Y., Benet, L.Z. (2005). Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22:11-23. 19. Lipinski, A. C. (2016). Rule of five in 2015 and beyond: Target ad ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Adv Drug Rev. 101: 34-41 20. Desa, S., Schwabe, A.,.McGlaughlin, M, Brown, C.E., Hyslop, R.M. (2017). Analysis of chemotypes in retail Cannabis strains. 253rd American Chemical Society National Meeting & Exposition, San Francisco, CA. 2-6 April, 2017. 21. Hyslop, R.M., Saviola, A., Bydalek, S., Brown, C.E., Desa, S., Thomas, M., Magiotta, A, Mackessy, S., Hansen, C., Brown, M. (2017). In vitro anti-neoplastic activity of specific phytocannabinoids of Cannabis sativa. 253rd American Chemical Society National Meeting & Exposition, San Francisco, CA. 2-6 April, 2017. 22. Hyslop, R.M., Brown, C.E., Magiotta A., Morgan, B., Brown, M., Sherman, T., Petty, D., Desa, S., O’Neil, J., Flora, S., Kellogg, K., Hansen, C., Bydalek, S., Cale, T., Laster, C., Folsom, J., Hawkinson, A. (2017). Development of a cannabinoid-based Cell-in-a Box® therapeutic system targeted toward malignant tumors. 253rd American Chemical Society National Meeting & Exposition, San Francisco, CA. 2-6 April, 2017. 23. Tian, S., Wang, J., Li, Y., Li, D., Xu, L., Hou, T. (2015). The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Delivery Reviews. 86: 2-10 24. Obata, Y., Ishikawa, Y. (1966). Studies on the Constituents of Hemp Plant (Cannabis sativa L.) Agricultural and Biological Chemistry. 30(6), 619-620 25. McPhail, A.T., ElSohly, H.N., Turner, C.E., ElSohly, M.A. (1984). Stereochemical assignments for the two enantiomeric pairs of 9,10-dihydroxy-Δ6a (10a) tetrahydrocannabinols x-ray crystal structure analysis of (±) trans-cannabitriol. J. Nat. Prod. 47(1):138–142 26. National Center for Biotechnology Information. PubChem Compound Database; CID=11551959, https://pubchem.ncbi.nlm.nih.gov/compound/11551959 (accessed Oct. 1, 2017). 27. El- Kattan, A., Varma, M. (2012). Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability, Topics on Drug Metabolism, Dr. James Paxton (Ed.), InTech, DOI: 10.5772/31087. Available from: https://www.intechopen.com/books/topics-on-drug-metabolism/oral-absorption-intestinal-metabolism-and-human-oral-bioavailability-